EC to purchase up to 160 mill doses of Moderna’s COVID-19 vaccine
Moderna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19
Read more
COVID-19
Coronavirus (COVID-19) pharmaceutical industry updates
Read the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
Trial data shows AstraZeneca’s COVID-19 vaccine was highly effective
AstraZeneca announced today, that interim trial data has shown it’s COVID-19 vaccine candidate AZD1222, developed in collaboration with the University
Read more
Moderna’s COVID-19 vaccine shows efficacy of 94.5% in Phase 3 trial
Moderna announced its vaccine candidate against COVID-19 named mRNA-1273, has met Phase 3 study statistical criteria with a vaccine efficacy
Read more
CureVac’s COVID-19 Vaccine stable at standard refrigerator temperature
CureVac, a German biopharmaceutical company developing innovative medicines based on messenger ribonucleic acid (mRNA), announced that its mRNA-based COVID-19 vaccine
Read more
Cold chain supply challenges for Pfizer and BioNTech’s COVID-19 vaccine
Governments around the world are scrambling to prepare for the rollout of the Pfizer and BioNTech COVID-19 vaccine, with many
Read more
Pfizer & BioNTech to supply EU with 200 million COVID-19 vaccine doses
Pfizer and BioNTech announced this week that they have reached an agreement with the European Commission to supply 200 million
Read more
Pfizer and BioNTech announce important COVID-19 vaccine breakthrough
Pfizer and BioNTech have announced their mRNA-based vaccine candidate for COVID-19, tested in a Phase 3 study involving 43,538 participants,
Read more
Vaccine Manufacturing and R&D Facility, Novavax, Gaithersburg, Maryland
Novavax has announced the expansion of its Gaithersburg, Maryland campus to support global vaccine development through the addition of two
Read more
Sanofi & GSK to support COVAX with 200 m adjuvanted recombinant protein-based COVID-19 vaccines
Sanofi and GSK plan to make available to the Gavi lead COVAX Facility 200 million doses of their adjuvanted recombinant
Read more
Lilly to supply 300,000 vials of COVID-19 monoclonal antibody to the U.S.
Eli Lilly and Company officially announced on Oct. 28, an initial deal with the U.S. government to supply 300,000 vials
Read more